51![Guidance for Industry Analytical Procedures and Methods Validation for Drugs and Biologics DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Guidance for Industry Analytical Procedures and Methods Validation for Drugs and Biologics DRAFT GUIDANCE This guidance document is being distributed for comment purposes only.](https://www.pdfsearch.io/img/9156b3242f7355e433397c85454246bc.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
52![DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Food and Drug Administration Center for Biologics Evaluation and Research[removed]New Hampshire Ave DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Food and Drug Administration Center for Biologics Evaluation and Research[removed]New Hampshire Ave](https://www.pdfsearch.io/img/b117270cda096ad775843299e19ff457.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
53![DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 1401 Rockville Pike DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 1401 Rockville Pike](https://www.pdfsearch.io/img/b13baa027966a1a578e3898390bb1e65.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
54![DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Silver Spring MD[removed]CBER REGULATORY REVIEW MEMORANDUM Date DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Silver Spring MD[removed]CBER REGULATORY REVIEW MEMORANDUM Date](https://www.pdfsearch.io/img/1df7300576ce7bc3bd4e337bb4a9d621.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
55![[removed]Federal Register / Vol. 80, No[removed]Tuesday, March 3, [removed]Notices TABLE 3—ESTIMATED ANNUAL REPORTING BURDEN FOR BIOLOGICS 1—Continued[removed]b), Number of submissions to FDA of ‘‘supporting informati [removed]Federal Register / Vol. 80, No[removed]Tuesday, March 3, [removed]Notices TABLE 3—ESTIMATED ANNUAL REPORTING BURDEN FOR BIOLOGICS 1—Continued[removed]b), Number of submissions to FDA of ‘‘supporting informati](https://www.pdfsearch.io/img/b8670fe7b103cf1f4794d4feebcbee17.jpg) | Add to Reading ListSource URL: www.gpo.govLanguage: English - Date: 2015-03-03 11:27:09
|
---|
56![Microsoft Word - 10970dft.doc Microsoft Word - 10970dft.doc](https://www.pdfsearch.io/img/5714c8caf7970950b6d44d5199c8ddec.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
57![6728 ACTION: Federal Register / Vol. 80, No[removed]Friday, February 6, [removed]Notices Notice of meeting. 6728 ACTION: Federal Register / Vol. 80, No[removed]Friday, February 6, [removed]Notices Notice of meeting.](https://www.pdfsearch.io/img/c877eaa920d1ce1cac20d618370846ae.jpg) | Add to Reading ListSource URL: www.gpo.govLanguage: English - Date: 2015-02-06 13:06:20
|
---|
58![Federal Register / Vol. 80, No[removed]Thursday, February 26, [removed]Notices title04/0403.htm. Karl Koerper, Reports Clearance Officer. [FR Doc. 2015–03924 Filed 2–25–15; 8:45 am] BILLING CODE 4184–73–P Federal Register / Vol. 80, No[removed]Thursday, February 26, [removed]Notices title04/0403.htm. Karl Koerper, Reports Clearance Officer. [FR Doc. 2015–03924 Filed 2–25–15; 8:45 am] BILLING CODE 4184–73–P](https://www.pdfsearch.io/img/1575d3f0a0c4e871325f0d06fedfc24b.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
59![Microsoft Word - 16618dft.doc Microsoft Word - 16618dft.doc](https://www.pdfsearch.io/img/869fa50b5391b3935b444f79f090e9aa.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
60![FDA’s Initiatives to Closing the Regulatory Science Knowledge Gap Leslie D. Wheelock, RN, MS Director, Office of Scientific Professional Development Office of the Chief Scientist FDA’s Initiatives to Closing the Regulatory Science Knowledge Gap Leslie D. Wheelock, RN, MS Director, Office of Scientific Professional Development Office of the Chief Scientist](https://www.pdfsearch.io/img/ab2163d987cea24cfd73adf666322b49.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|